Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             211 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2010
 20 S1 p. S83-S87
5 p.
 artikel
2 Editorial Board 2010
 20 S1 p. i-
1 p.
 artikel
3 OL Longevity genes: parlor trick or path to drugs that revolutionize medicine Sinclair, D.
 2010
 20 S1 p. S1-
1 p.
 artikel
4 OR3,16 Abnormal MRI in GH-deficient patients: association with clinical presentation, hormonal status and 1st year GH response Deal, C.
 2010
 20 S1 p. S8-
1 p.
 artikel
5 OR3,17 Acromegaly is associated with enhanced renal and extrarenal epithelial sodium channel (ENaC) activity in humans Kamenicky, P.
 2010
 20 S1 p. S9-
1 p.
 artikel
6 OR2,12 Adipokines, and central fat mass have a higher impact on peak GH during the GHRH+arginin test than the insulin tolerance test Klose, M.
 2010
 20 S1 p. S6-
1 p.
 artikel
7 OR12,67 Age-dependent control of Akt phosphorylation in muscles from IGFBP-2 transgenic mice as a potential target for the metabolic effects of IGFBP-2 Hoeflich, A.
 2010
 20 S1 p. S31-
1 p.
 artikel
8 OR5,27 A novel approach involving a sensitized chemical mutagenesis screen to identify genes that interact with GH signaling pathway to regulate skeletal phenotype Mohan, S.
 2010
 20 S1 p. S12-S13
2 p.
 artikel
9 OR2,9 A novel human growth hormone XTEN construct (VRS-317) for once-a-month subcutaneous administration Cleland, J.L.
 2010
 20 S1 p. S5-
1 p.
 artikel
10 OR13,73 A novel mechanism to inhibit IGF-I and prevent the development of diabetic retinopathy Maile, L.A.
 2010
 20 S1 p. S33-
1 p.
 artikel
11 OR6,32 A novel role of insulin-like growth factor binding protein (IGFBP)-5 in calcium homeostasis in zebrafish embryos Dai, W.
 2010
 20 S1 p. S14-
1 p.
 artikel
12 OR4,24 A phosphoproteomic view of the IGF-II signaling Vallejo, A.F.
 2010
 20 S1 p. S11-
1 p.
 artikel
13 OR1,1 b cell specific disruption of the growth hormone receptor impair b cell insulin secretion Wu, Y.
 2010
 20 S1 p. S2-
1 p.
 artikel
14 OR14,82 Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections. Implications for detection of GH abuse Krusenstjerna-Hafstrøm, T.
 2010
 20 S1 p. S36-S37
2 p.
 artikel
15 OR9,51 Brown adipose tissue is present in PET negative supraclavicular fat in adult humans Lee, P.
 2010
 20 S1 p. S23-S24
2 p.
 artikel
16 OR7,41 Can metabolomics be used to identify new markers of growth hormone deficiency? Hoybye, C.
 2010
 20 S1 p. S19-
1 p.
 artikel
17 OR6,36 Characterization of a putative ‘BH3-like’ domain establishes IGFBP-3 as a unique intrinsic pathway activator that integrates cell survival and death signals in the mitochondrial regulatory network Paharkova-Vatchkova, V.
 2010
 20 S1 p. S16-
1 p.
 artikel
18 OR11,66 Characterization of four human growth hormone mutants found in patients with retarded growth Hennig, M.
 2010
 20 S1 p. S30-S31
2 p.
 artikel
19 OR3,18 Clinical, genetic and molecular characterisation of patients with familial isolated pituitary adenomas (FIPA), especially GH-secreting adenomas Trivellin, G.
 2010
 20 S1 p. S9-
1 p.
 artikel
20 OR13,78 Compensatory activation of insulin receptor (IR) upon inhibition of insulin-like growth factor-1 receptor (IGF-1R): Rationale for co-targeting IGF-1R and IR in cancer Buck, E.
 2010
 20 S1 p. S35-
1 p.
 artikel
21 OR9,50 Components of the IGF system are readily detectable in the interstitial fluid when evacuated by ‘suction blister’ technique Espelund, U.
 2010
 20 S1 p. S23-
1 p.
 artikel
22 OR1,6 Diet induced obesity in growth hormone antagonist mice Yang, T.
 2010
 20 S1 p. S4-
1 p.
 artikel
23 OR8,48 Differential impacts of IGFBP-3 in epithelial IGF-induced lung cancer development Kim, W.-Y.
 2010
 20 S1 p. S21-
1 p.
 artikel
24 OR5,30 Distinct epigenetic actions of growth hormone and Stat5b Chia, D.J.
 2010
 20 S1 p. S13-S14
2 p.
 artikel
25 OR9,52 Dynamic relationship of IGFBP-1 and insulin during euglycemic glucose clamp in type 2 diabetes restored by rosiglitazone Tint, M.T.
 2010
 20 S1 p. S24-
1 p.
 artikel
26 OR4,22 Effects of IGF-1 receptor heterozygosity on glucose metabolism Garg, N.
 2010
 20 S1 p. S10-S11
2 p.
 artikel
27 OR1,4 Effects of low-carbohydrate/high-fat (LCHF) diets on the growth hormone (GH)/insulin like growth factor (IGF) system in rats Stoehr, B.J.M.
 2010
 20 S1 p. S3-
1 p.
 artikel
28 OR13,76 Effects of metformin on hyperglycaemia-induced chemoresistance of DU145 and LNCaP prostate cancer cells Biernacka, K.
 2010
 20 S1 p. S34-
1 p.
 artikel
29 OR14,79 Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome de Lind van Wijngaarden, R.F.A.
 2010
 20 S1 p. S35-
1 p.
 artikel
30 OR4,23 ER chaperone GRP94 depletion in skeletal muscle reduces muscle and organismal growth through inhibition of IGF-I production Barton, E.
 2010
 20 S1 p. S11-
1 p.
 artikel
31 OR7,40 Evaluation of between-methods agreement of extracellular water measurements in adults with growth hormone deficiency (GHD) Barbosa, E.
 2010
 20 S1 p. S18-S19
2 p.
 artikel
32 OR2,11 Evidence in support of luminal versus circulating octanoate for ghrelin O-acyl transferase (GOAT)-mediated acylation of ghrelin Thorner, M.O.
 2010
 20 S1 p. S6-
1 p.
 artikel
33 OR12,72 Explore the mechanism of growth hormone signaling with growth hormone receptor monoclonal antibodies Wu, Z.
 2010
 20 S1 p. S32-S33
2 p.
 artikel
34 OR4,20 Free IGF-1 enhances somatic growth and skeletal architecture Courtland, H.-W.
 2010
 20 S1 p. S10-
1 p.
 artikel
35 OR2,7 Gender difference in neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators Birzniece, V.
 2010
 20 S1 p. S4-
1 p.
 artikel
36 OR11,61 Genetic markers associated with 1 month change in IGF-I and growth at 1 year during GH therapy in children with GH deficiency: The PREDICT study and follow-up highlight genetic contributions to individual response Clayton, P.
 2010
 20 S1 p. S28-
1 p.
 artikel
37 OR5,28 GH-induced activation of JAK/STAT signaling in osteosarcoma cells is inhibited by statins through the induction of SOCS expression Sandoval-Usme, M.C.
 2010
 20 S1 p. S13-
1 p.
 artikel
38 OR7,39 GH responsiveness in hypopituitary patients with very severe adult GHD using insulin, arginine or glucagon stimulation tests is associated with IGF-I SDS but not with the stimulated GH peak Feldt-Rasmussen, U.
 2010
 20 S1 p. S18-
1 p.
 artikel
39 OR12,69 Growth hormone enhances breast cancer chemoresistance by protecting from apoptosis Zatelli, M.C.
 2010
 20 S1 p. S31-S32
2 p.
 artikel
40 OR11,64 Growth hormone (GH) induces a dose-dependent, long-term increase in growth in pre-pubertal children with GH deficiency (GHD) without modifying the rate of initiation of puberty Cohen, P.
 2010
 20 S1 p. S29-S30
2 p.
 artikel
41 OR11,63 Growth hormone treatment has a positive effect on spine bone mineral density in young adults with childhood-onset growth hormone deficiency: a meta-analysis Kappelgaard, A.-M.
 2010
 20 S1 p. S29-
1 p.
 artikel
42 OR10,55 GSK-3beta regulates insulin-like growth factor receptor tyrosine kinase activity by phosphorylation of S1248 in the C-terminus Kelly, G.M.
 2010
 20 S1 p. S25-
1 p.
 artikel
43 OR6,35 Heparin binding properties of the IGF-II/IGFBP-2 complex Lund, J.
 2010
 20 S1 p. S15-S16
2 p.
 artikel
44 OR9,53 Higher circulating IGF-I bioactivity and total IGF-I with intraperitoneal insulin delivery than with CSII in type 1 diabetes Arnqvist, H.
 2010
 20 S1 p. S24-S25
2 p.
 artikel
45 OR6,33 Hyperglycaemia reduces the efficacy of chemotherapeutic agents in DU145 prostate cancer (CaP) cells: Involvement of IGFBP-2 Perks, C.M.
 2010
 20 S1 p. S14-S15
2 p.
 artikel
46 OR6,31 Identification and functional characterization of an ancient IGFBP from Amphioxus: Evolution of the IGFBP family Zhou, J.
 2010
 20 S1 p. S14-
1 p.
 artikel
47 OR9,54 IGFBP-6 and IGF-II: novel mediators of myofibroblast differentiation in Dupuytren's Disease? Raykha, C.
 2010
 20 S1 p. S25-
1 p.
 artikel
48 OR6,34 IGFBP-3 is a metastasis suppression gene for prostate cancer Mehta, H.
 2010
 20 S1 p. S15-
1 p.
 artikel
49 OR10,60 IGF-IIR: A novel autocrine loop between IGF-II and hCG Freyre, S.I.
 2010
 20 S1 p. S27-
1 p.
 artikel
50 OR4,21 IGF-I receptor blockade ameliorates the smooth muscle hyperplasia and fibrosis of TNBS-induced colitis Flynn, R.S.
 2010
 20 S1 p. S10-
1 p.
 artikel
51 OR10,58 IGF-I-responsive ribosomal protein WDR3 integrates 40S ribosome biogenesis with p53-mediated cell cycle regulation O'Connor, R.
 2010
 20 S1 p. S26-
1 p.
 artikel
52 OR8,47 IGF-I:Vitronectin interactions modulate breast cancer cell survival, migration and epithelial to mesenchymal transition Upton, Z.
 2010
 20 S1 p. S21-
1 p.
 artikel
53 OR12,71 IGF2 promotes murine forebrain neural stem/progenitor cell self-renewal via the insulin receptor Ziegler, A.
 2010
 20 S1 p. S32-
1 p.
 artikel
54 OR8,44 Increased levels of circulating IGF-I normalizes mammary gland development in mice deficient of local IGF-1 Cannata, D.H.
 2010
 20 S1 p. S20-
1 p.
 artikel
55 OR13,77 Insulin-like growth factors (IGFs) and IGF binding proteins in PSA-detected prostate cancer: a population-based case control study Rowlands, M.-A.
 2010
 20 S1 p. S34-S35
2 p.
 artikel
56 OR10,57 Insulin-like growth factor signaling regulates stem/progenitor cells in the epithelium of virgin mouse mammary glands Lazzarino, D.A.
 2010
 20 S1 p. S26-
1 p.
 artikel
57 OR10,56 Insulin receptor substrate-1 localized around endosomes, sorted by adaptor protein-1 complex, transmits insulin/IGF signals to specific Akt substrates Yoneyama, Y.
 2010
 20 S1 p. S26-
1 p.
 artikel
58 OR12,68 Insulin receptor substrates (IRSs) form a complex with RNAs, affecting RNA metabolism and translation Atsufumi, O.
 2010
 20 S1 p. S31-
1 p.
 artikel
59 OR7,37 Interaction between testosterone and growth hormone on whole body protein anabolism is mediated through the liver Birzniece, V.
 2010
 20 S1 p. S17-
1 p.
 artikel
60 OR13,74 Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A Conover, C.A.
 2010
 20 S1 p. S33-
1 p.
 artikel
61 OR4,19 Loss of neuronal IGF receptors increases somatotropic hormone signaling and accelerates aging in mice Xu, J.
 2010
 20 S1 p. S9-S10
2 p.
 artikel
62 OR7,38 Measurement of free GH and bioactive IGF-I in non-diabetic hemodialysis patients treated with rh-GH for 7 days Frystyk, J.
 2010
 20 S1 p. S17-S18
2 p.
 artikel
63 OR10,59 Mechanism of regulation of placental mesenchymal stem cell (PMSC) fate by insulin-like growth factors (IGFs) under low oxygen tension Youssef, A.
 2010
 20 S1 p. S26-S27
2 p.
 artikel
64 OR2,10 Metabolic effects of tesamorelin, a growth hormone-releasing hormone analogue, in HIV-infected patients with excess abdominal fat: a pooled analysis of 2 multicenter, randomized, placebo-controlled phase 3 trials Falutz, J.
 2010
 20 S1 p. S5-S6
2 p.
 artikel
65 OR14,80 Octreolin™, a safe oral alternative for parenteral octreotide treatment Tuvia, S.
 2010
 20 S1 p. S35-S36
2 p.
 artikel
66 OR3,15 Pegvisomant added to somatostatin analogue treatment increases intrahepatic but decreases intramuscular lipid content in acromegalic patients Madsen, M.
 2010
 20 S1 p. S8-
1 p.
 artikel
67 OR2,8 Phase I PK&PD profile of long acting bio-better CTP modified hGH (MOD-4023) in healthy volunteers Havron, A.
 2010
 20 S1 p. S4-S5
2 p.
 artikel
68 OR5,26 Post-receptor changes in GH signaling pathway of the epiphyseal growth plate in a rat model of chronic kidney disease related growth retardation Wiezel, D.
 2010
 20 S1 p. S12-
1 p.
 artikel
69 OR11,65 Randomized controlled trial on the effects of growth hormone therapy and nutritional supplementation in boys with constitutional growth delay Han, J.C.
 2010
 20 S1 p. S30-
1 p.
 artikel
70 OR14,83 rhGH/rhIGF-1 co-administration versus rhGH alone in short, prepubertal children with low IGF-1 and normal stimulated GH levels: first-year results from a Phase II, randomized, open-label, active-treatment controlled trial Midyett, L.K.
 2010
 20 S1 p. S37-
1 p.
 artikel
71 OR12,70 Role of GH-IGF-I excess on periodontal tissues Bondanelli, M.
 2010
 20 S1 p. S32-
1 p.
 artikel
72 OR1,5 Role of growth hormone signaling pathways in liver regeneration Ishikawa, M.
 2010
 20 S1 p. S3-S4
2 p.
 artikel
73 OR13,75 Role of IGF-I and IGFBPs in the fasting-induced protection of mice versus malignant cells against chemotherapy Lee, C.
 2010
 20 S1 p. S33-S34
2 p.
 artikel
74 OR8,46 ROS Accumulation and IGF-IR inhibition contribute to fenofibrate/PPARa-mediated inhibition of glioma cell motility in vitro Reiss, K.
 2010
 20 S1 p. S20-S21
2 p.
 artikel
75 OR7,42 Serum proteomic profiles in GH-deficient patients before and after GH substitution Cruz-Topete, D.
 2010
 20 S1 p. S19-
1 p.
 artikel
76 OR5,25 Sirt1 negatively regulates IGF-I production by growth hormone in hepatocytes Yamamoto, M.
 2010
 20 S1 p. S12-
1 p.
 artikel
77 OR1,3 Stimulation of growth by a constitutively activated GHR and study of GHR signaling in early development of zebrafish Sun, Y.-H.
 2010
 20 S1 p. S3-
1 p.
 artikel
78 OR5,29 Structural and functional role of the C-terminal disulfide bridge of human growth hormone Junnila, R.K.
 2010
 20 S1 p. S13-
1 p.
 artikel
79 OR8,43 Structural insights into the binding of peptide agonists and antagonists to the Type 1 insulin-like growth factor receptor ectodomain – mimicking growth factor or mimicking the receptor? Lawrence, M.C.
 2010
 20 S1 p. S19-S20
2 p.
 artikel
80 OR14,81 SUN11031 (synthetic human Ghrelin) improves lean body mass and function in advanced COPD cachexia in a placebo controlled trial Gertner, J.
 2010
 20 S1 p. S36-
1 p.
 artikel
81 OR9,49 Suppression of insulin signaling in white adipose tissues contributes to preferential lipid accumulation in rat liver under protein malnutrition Toyoshima, Y.
 2010
 20 S1 p. S22-S23
2 p.
 artikel
82 OR1,2 Targeted ablation of growth hormone receptors in the skeletal muscle improves metabolism and protects against diet-induced obesity in mice Vijayakumar, A.
 2010
 20 S1 p. S2-
1 p.
 artikel
83 OR11,62 The effect of genotype on molecular mechanisms leading to the 3-M primordial growth disorder Coulson, T.
 2010
 20 S1 p. S28-S29
2 p.
 artikel
84 OR8,45 The IGF-I inducible pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells Favre, C.
 2010
 20 S1 p. S20-
1 p.
 artikel
85 OR3,14 The influence of IGF-I normalization on cardiovascular risk in patients with uncontrolled and long-term acromegaly in comparison to matched data from the general population Berg, C.
 2010
 20 S1 p. S7-S8
2 p.
 artikel
86 OR3,13 Tumor recurrence and enlargement during more than 10 years growth hormone replacement therapy in patients with craniopharyngioma Olsson, D.S.
 2010
 20 S1 p. S7-
1 p.
 artikel
87 OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD) Saenger, P.H.
 2010
 20 S1 p. S37-S38
2 p.
 artikel
88 P29 Acyl-ghrelin secretion declines over a 37.5-h fast in healthy young men Nass, R.
 2010
 20 S1 p. S50-
1 p.
 artikel
89 P16 Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP): reference range and levels in children with idiopathic short stature treated with growth hormone Olney, R.C.
 2010
 20 S1 p. S45-
1 p.
 artikel
90 P48 Analysis of novel mTOR targets during oligodendrocyte differentiation Cifelli, S.E.
 2010
 20 S1 p. S56-S57
2 p.
 artikel
91 P64 Analysis of the interplay between the insulin receptor and IGF-I receptor signaling pathways in prostate cancer Weinstein, D.
 2010
 20 S1 p. S62-
1 p.
 artikel
92 P26 An individualized, target-driven treatment regimen for children with idiopathic short stature (ISS) Wajnrajch, M.P.
 2010
 20 S1 p. S49-
1 p.
 artikel
93 P63 A novel role of the insulin-like growth factor-II receptor (IGF-IIR) in the regulation of the biological effects of IGFs in a trophoblast cell line Vallejo, A.
 2010
 20 S1 p. S61-
1 p.
 artikel
94 P103 Anti-Müllerian Hormone (AMH) in short girls born Small for Gestational Age (SGA) and the effect of growth hormone (GH) treatment Lem, A.
 2010
 20 S1 p. S78-
1 p.
 artikel
95 P59 Antitumor response of preclinical tumor models to IGF-IR targeted therapy is not dependent on PTEN or PIK3CA mutational status Deevi, D.S.
 2010
 20 S1 p. S60-
1 p.
 artikel
96 P56 A nuclear complex of Rictor and IRS2 is associated with albuminuria in diabetic mice Mascarenhas, D.
 2010
 20 S1 p. S59-
1 p.
 artikel
97 P72 Are IGFBP-1 and leptin predictor of diabetes in children and adults with low birth weight? Kistner, A.
 2010
 20 S1 p. S64-
1 p.
 artikel
98 P45 Autocrine role of the IGF-II/IGF-IIR system in trophoblastic cell differentiation Alarcón, J.C.
 2010
 20 S1 p. S55-S56
2 p.
 artikel
99 P22 Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation therapy Elbornsson, M.
 2010
 20 S1 p. S47-S48
2 p.
 artikel
100 P18 Baseline characteristics and quality of life in patients with childhood-onset growth hormone deficiency due to Cushing's disease and non-functioning pituitary adenoma Ragnarsson, O.
 2010
 20 S1 p. S46-
1 p.
 artikel
101 P90 Biomarkers of growth hormone doping in healthy human subjects Ding, J.
 2010
 20 S1 p. S72-
1 p.
 artikel
102 P71 Biomarkers of inflammation and nutrition in female Olympic athletes Hagmar, M.
 2010
 20 S1 p. S64-
1 p.
 artikel
103 P39 Both the insulin receptor isoform a and the IGF-I receptor mediate the effects of IGF-II in human thyroid stem cells Malaguarnera, R.
 2010
 20 S1 p. S53-S54
2 p.
 artikel
104 P106 Can IGFBP-1 level predict hepatic steatosis? Gupta, R.
 2010
 20 S1 p. S79-
1 p.
 artikel
105 P30 Characterization of growth hormone disulfide-linked molecular isoforms during post-exercise release vs. nocturnal pulsatile release reveals similar milieu composition Nind, B.C.
 2010
 20 S1 p. S50-
1 p.
 artikel
106 P37 Comparative study of the IGF system biological effects in HPV positive and negative cervical cancer cell lines Garay-Baquero, D.
 2010
 20 S1 p. S53-
1 p.
 artikel
107 P11 Comparison of intuitiveness, ease of use and preference in three growth hormone injection devices Kappelgaard, A.-M.
 2010
 20 S1 p. S42-S43
2 p.
 artikel
108 P83 Comparison of the serum levels of insulin-like growth factor 1, IGF binding protein 1 with their mRNA levels expressed in human carotid plaques Wang, J.
 2010
 20 S1 p. S69-
1 p.
 artikel
109 P53 Continuous activation of IGF signaling inhibits myogenic differentiation of L6 myoblasts Hakuno, F.
 2010
 20 S1 p. S58-
1 p.
 artikel
110 P49 Cortical bone accrual in the adult mouse is unaffected by reductions in serum IGF-1 after peak bone acquisition Courtland, H.-W.
 2010
 20 S1 p. S57-
1 p.
 artikel
111 P51 Defective chemotaxis of lymphoid cells to L. monocytogenes infection in serum IGF-I restricted mice Cuervo-Escobar, S.
 2010
 20 S1 p. S57-S58
2 p.
 artikel
112 P61 Deficiency of insulin-like growth factor 1 receptor confers resistance to oxidative stress in C2C12 myoblasts Thakur, S.
 2010
 20 S1 p. S61-
1 p.
 artikel
113 P92 Determining reliable threshold limits for the GH-2000 detection methodology using 496 samples collected from elite athletes and current IGF-I & P-III-P assay methodologies Erotokritou-Mulligan, I.
 2010
 20 S1 p. S73-
1 p.
 artikel
114 P91 Differential effects of growth hormone and insulin-like growth factor-1 on the mouse plasma proteome Ding, J.
 2010
 20 S1 p. S72-S73
2 p.
 artikel
115 P47 Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes – role of insulin and IGF-I receptors Bäck, K.
 2010
 20 S1 p. S56-
1 p.
 artikel
116 P31 Earlier start of puberty in GH treated children born SGA than in GH treated for GHD. Data from the NordiNet® IOS Rakov, V.
 2010
 20 S1 p. S51-
1 p.
 artikel
117 P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients Gatto, F.
 2010
 20 S1 p. S71-
1 p.
 artikel
118 P50 Effect of GH/IGF-1 supplementation in ALS-deficient mice Courtland, H.-W.
 2010
 20 S1 p. S57-
1 p.
 artikel
119 P108 Effect of intensive insulin therapy on the somatotropic axis in critically ill children Gielen, M.
 2010
 20 S1 p. S80-
1 p.
 artikel
120 P95 Effects of GH and IGF-1 treatments on body composition, glucose metabolism and hepatic gene expression in obese/diabetic mice with nonalcoholic fatty liver disease List, E.O.
 2010
 20 S1 p. S74-S75
2 p.
 artikel
121 P23 Effects of 3-year growth hormone (GH) replacement therapy on bone mineral density in younger and elderly adults with adult onset GH deficiency Elbornsson, M.
 2010
 20 S1 p. S48-
1 p.
 artikel
122 P78 Elimination of acute drug side effects without loss of efficacy by site-specific PEGylation of insulin-like growth factor I Metzger, F.
 2010
 20 S1 p. S67-
1 p.
 artikel
123 P57 Expression of myosin heavy chain isoforms is mediated by IGF-IEa and IGF-IEb Matheny, W.
 2010
 20 S1 p. S59-S60
2 p.
 artikel
124 P98 Extreme body growth and protein accretion under normal serum IGF-I concentrations in male but not in female mice – new models and new challenges for the somatomedin hypothesis Sawitzky, M.
 2010
 20 S1 p. S75-S76
2 p.
 artikel
125 P24 Fifteen-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency Elbornsson, M.
 2010
 20 S1 p. S48-
1 p.
 artikel
126 P44 Functional study on beta-arrestins involvement in Ras induced transformation of mammalian cells Zheng, H.
 2010
 20 S1 p. S55-
1 p.
 artikel
127 P9 Ghrelin test: a new tool for the diagnosis of GH deficiency in adults Gasco, V.
 2010
 20 S1 p. S42-
1 p.
 artikel
128 P102 Growth hormone-induced oscillations in cytosolic free Ca2+ in single rat hepatocytes, modulation by different agonists Marrero, I.
 2010
 20 S1 p. S77-S78
2 p.
 artikel
129 P5 Growth hormone treatment for iatrogenic Cushing's syndrome Choi, Y.-J.
 2010
 20 S1 p. S41-
1 p.
 artikel
130 P10 Hypopituitarism following traumatic brain injury and subarachnoid hemorrhage: a prospective study Jonasdottir, A.D.
 2010
 20 S1 p. S42-
1 p.
 artikel
131 P104 Identification of a novel cell death receptor (IGFBP-3R) mediating IGFBP-3-induced antitumor effects in human cancer Oh, Y.
 2010
 20 S1 p. S78-S79
2 p.
 artikel
132 P55 Identification of the IAP binding site for SHPS-1 and its role in the regulation of IGF-I signaling Maile, L.A.
 2010
 20 S1 p. S59-
1 p.
 artikel
133 P70 IGFBP-2 acts as a survival factor in breast cancer cells Foulstone, E.
 2010
 20 S1 p. S63-S64
2 p.
 artikel
134 P73 IGFBP-2 enhances VEGF gene promoter activity and angiogenic activities in neuroblastoma cells Azar, W.J.
 2010
 20 S1 p. S65-
1 p.
 artikel
135 P65 IGF-I-FOXO3a counteracts high glucose/TNFa-mediated neuronal damage in vitro: associations with HIV dementia Wilk, A.
 2010
 20 S1 p. S62-
1 p.
 artikel
136 P86 IGF-I/IGFBP-1 system in young subjects newly diagnosed with type 1 Diabetes Mellitus Forsberg, E.
 2010
 20 S1 p. S70-
1 p.
 artikel
137 P52 IGF-1R and LL37 – a promoting growth interaction Girnita, A.
 2010
 20 S1 p. S58-
1 p.
 artikel
138 P58 IGF-1 Regulates S and G2/M phases of the cell cycle in CNS progenitor cells Min, J.
 2010
 20 S1 p. S60-
1 p.
 artikel
139 P110 IGF signaling regulates catch-up growth and accelerated developmental timing in zebrafish embryos in response to oxygen availability Kamei, H.
 2010
 20 S1 p. S81-
1 p.
 artikel
140 P34 Increased mammary tumor lung metastases in an MKR mouse model of type 2 diabetes Ferguson, R.D.
 2010
 20 S1 p. S52-
1 p.
 artikel
141 P1 Influence of the d3-GH receptor and IGF1 gene polymorphisms on IGF1 and lipid profile on short and long-term treatment response in adult GH deficiency Barbosa, E.
 2010
 20 S1 p. S39-
1 p.
 artikel
142 P96 Insulin and insulin-like growth factor ii induce differential endocytic sorting of the insulin receptor isoform A Morrione, A.
 2010
 20 S1 p. S75-
1 p.
 artikel
143 P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines Arvigo, M.
 2010
 20 S1 p. S63-
1 p.
 artikel
144 P28 Insulin resistance induced by GH is transient and reversible: glucose clamp studies during different ambient GH levels in GH-deficient adults Jørgensen, J.O.L.
 2010
 20 S1 p. S49-S50
2 p.
 artikel
145 P43 Involvement of IGFBP-3 in the growth inhibitory effects of AZA on MDA-MB-231 breast cancer cells Zeng, L.
 2010
 20 S1 p. S55-
1 p.
 artikel
146 PL2 Consensus with feet of clay? Diagnostic guidelines and GH assay variability Bidlingmaier, M.
 2010
 20 S1 p. S1-S2
2 p.
 artikel
147 PL3 Conserved IGF-I-regulated genes and the prevention and treatment of age-related diseases Longo, V.
 2010
 20 S1 p. S6-
1 p.
 artikel
148 PL1 Genomic approaches to unraveling the complexity of GH-regulated liver sex differences Waxman, D.
 2010
 20 S1 p. S1-
1 p.
 artikel
149 PL7 GH and fat distribution: To be and where to be Berryman, D.
 2010
 20 S1 p. S16-
1 p.
 artikel
150 P14 Lifelong serum growth hormone levels in untreated patients with Laron syndrome Laron, Z.
 2010
 20 S1 p. S44-
1 p.
 artikel
151 PL8 IGF-1 receptor in adults: What the cell-specific knockouts tell us Holzenberger, M.
 2010
 20 S1 p. S16-S17
2 p.
 artikel
152 PL5 Molecular mechanisms underlying IGF action Forbes, B.
 2010
 20 S1 p. S11-S12
2 p.
 artikel
153 P15 Long-term administration of hGH or IGF-I increase body adiposity and serum cholesterol Laron, Z.
 2010
 20 S1 p. S44-S45
2 p.
 artikel
154 P79 Low dose insulin-like growth factor-1 has potent early anti-apoptotic and signaling effects, and long-term structural, remodeling, and functional benefits post ischemia-reperfusion O'Sullivan, J.F.
 2010
 20 S1 p. S67-
1 p.
 artikel
155 PL4 Role of GH/IGF-I in adaptation of matrix in skeletal muscle and tendon to exercise Kjær, M.
 2010
 20 S1 p. S7-
1 p.
 artikel
156 PL9 Strategies for identifying genes involved in cell lineage specification and expansion: from stem cell to hormone producing cells Camper, S.
 2010
 20 S1 p. S22-
1 p.
 artikel
157 PL6 Targeting the IGF pathway in breast cancer Lee, A.
 2010
 20 S1 p. S12-
1 p.
 artikel
158 PL10 The curious case of ghrelin Korbonits, M.
 2010
 20 S1 p. S22-
1 p.
 artikel
159 PL12 Twenty years of efficacy and safety information with recombinant human IGF-I therapy: How will our clinical experience alter the approach to the treatment of short stature? Backeljauw, P.
 2010
 20 S1 p. S27-S28
2 p.
 artikel
160 PL11 Who needs IGFs? IGFBP-3 activates growth-stimulatory pathways Baxter, R.
 2010
 20 S1 p. S27-
1 p.
 artikel
161 P3 Macimorelin, an oral ghrelin-mimetic GH secretagogue, as a potential diagnostic test for adult GH deficiency Biller, B.M.K.
 2010
 20 S1 p. S40-
1 p.
 artikel
162 P60 Mechanisms for glutamate exicitotoxicity and IGF-I survival in late OPCs Simonishvili, S.
 2010
 20 S1 p. S60-S61
2 p.
 artikel
163 P17 Mental functioning improvement on growth hormone replacement in growth hormone deficient patients after traumatic brain injury Doknic, M.
 2010
 20 S1 p. S45-
1 p.
 artikel
164 P42 Metformin displays antiproliferative activities in endometrial cancer cells via interaction with the IGF-1R signaling axis Werner, H.
 2010
 20 S1 p. S54-S55
2 p.
 artikel
165 P75 Mutated IGF-I receptor (D1105E) extinguish autophosphorylation: A family of short stature born intrauterine growth retardation bearing a novel missense mutation of the IGF-I receptor Kawashima, Y.
 2010
 20 S1 p. S66-
1 p.
 artikel
166 P69 Neutrophil-derived azurocidin proteolyses IGF binding protein-1, -2 and -4 Brandt, K.
 2010
 20 S1 p. S63-
1 p.
 artikel
167 P74 New IGF-1 normative data for healthy, Contemporary US children Chandler, D.W.
 2010
 20 S1 p. S65-
1 p.
 artikel
168 P12 Norditropin increases lean muscle, reduces fat mass and normalizes height in children with Prader-Willi Syndrome Kappelgaard, A.-M.
 2010
 20 S1 p. S43-
1 p.
 artikel
169 P13 Patient Perception of injection pain and anxiety: a comparison of two pen injection device systems, Norditropin® FlexPro® with FlexPro® PenMate®, and Norditropin NordiFlex® with NordiFlex PenMate® Kappelgaard, A.-M.
 2010
 20 S1 p. S44-
1 p.
 artikel
170 P2 Pegvisomant therapy in acromegaly: a multicenter Bianchi, A.
 2010
 20 S1 p. S39-
1 p.
 artikel
171 P19 PenMate evaluation in growth hormone (GH) treated children injecting themselves in comparison with GH treated children injected by their parents Hokken-Koelega, A.
 2010
 20 S1 p. S46-S47
2 p.
 artikel
172 P20 Pharmacokinetic-pharmacodynamic model for a pegylated, long-acting human growth hormone developed for once-weekly administration Rasmussen, M.H.
 2010
 20 S1 p. S47-
1 p.
 artikel
173 P67 PI 3-kinase activation through c-Src-dependent tyrosine phosphorylation of PITKAP/XB130, a novel binding partner of a PI 3-kinase p85 regulatory subunit, plays novel roles in priming cells to IGF Yamanaka, D.
 2010
 20 S1 p. S62-S63
2 p.
 artikel
174 P27 Pituitary choriocarcinoma in an adolescent: tumor-derived CG and GHv delay presentation Wildi-Runge, S.
 2010
 20 S1 p. S49-
1 p.
 artikel
175 P81 Pituitary insufficiency in the acute phase of traumatic brain injury or subarachnoid hemorrhage: a prospective study Sigurjonsson, P.
 2010
 20 S1 p. S68-
1 p.
 artikel
176 P88 Plasma levels of insulin-like growth factor-I, insulin-like growth factor binding protein-1, coenzyme Q10 and vitamin E in Kenyan populations Tekle, M.
 2010
 20 S1 p. S71-
1 p.
 artikel
177 P82 Positive clinical results with vitronectin: IGF complexes for the treatment of chronic wounds Upton, Z.
 2010
 20 S1 p. S68-S69
2 p.
 artikel
178 P77 Postnatal serum IGF-1 deficiency is associated with bronchopulmonary dysplasia Lofqvist, C.
 2010
 20 S1 p. S66-S67
2 p.
 artikel
179 P7 Predictors of pituitary dysfunction in patients surviving ischemic stroke Bondanelli, M.
 2010
 20 S1 p. S41-
1 p.
 artikel
180 P100 Prevalence of IGF-1 deficiency (IGFD) among ISS patients Lazareva, O.
 2010
 20 S1 p. S77-
1 p.
 artikel
181 P40 Proinsulin mediates proliferative effects by activating the isoform a of the insulin receptor Sacco, A.
 2010
 20 S1 p. S54-
1 p.
 artikel
182 P76 Prolactin serum levels in untreated and IGF-I treated patients with Laron syndrome are elevated and suppressed by IGF-I treatment Laron, Z.
 2010
 20 S1 p. S66-
1 p.
 artikel
183 P89 Recombinant human GH stimulates IGF-I mRNA expression and secretion in hepatocytes of C57BL/6 mice in vitro, but not in vivo Bielohuby, M.
 2010
 20 S1 p. S72-
1 p.
 artikel
184 P35 Reduced serum IGF-1 levels do not affect insulin-mediated mammary tumor progression in type 2 diabetes Fierz, Y.C.
 2010
 20 S1 p. S52-
1 p.
 artikel
185 P101 Regulation of osteoclast differentiation by the IGF binding protein IGFBP-2 Maile, L.A.
 2010
 20 S1 p. S77-
1 p.
 artikel
186 P25 Response of growth hormone release compared betwen growth hormone-releasing peptide-2 test and glucagon stimulation test in adults Tanimoto, K.
 2010
 20 S1 p. S48-
1 p.
 artikel
187 P107 rhIGF-1 therapy for growth failure and IGF-1 deficiency in Congenital Disorder of Glycosylation Ia Miller, B.S.
 2010
 20 S1 p. S79-S80
2 p.
 artikel
188 Program at a Glance 2010
 20 S1 p. vi-
1 p.
 artikel
189 P66 Role of IGF-1R signaling in uveal melanoma Worrall, C.
 2010
 20 S1 p. S62-
1 p.
 artikel
190 P41 Serum levels of insulin-like growth factor-I and oncogenic human papillomavirus natural history Serrano, M.-L.
 2010
 20 S1 p. S54-
1 p.
 artikel
191 P80 Serum markers of response in a neo-adjuvant clinical trial of the IGF-IR mabA12 in prostate cancer Plymate, S.
 2010
 20 S1 p. S68-
1 p.
 artikel
192 P6 Serum protein changes in acromegalic individuals following transsphenoidal surgery Cruz-Topete, D.
 2010
 20 S1 p. S41-
1 p.
 artikel
193 P21 Sheehan's syndrome in modern times Kristjansdottir, H.L.
 2010
 20 S1 p. S47-
1 p.
 artikel
194 P99 SHOX gene variants: growth hormone/IGF-1 status and response to growth hormone treatment Klein, M.L.
 2010
 20 S1 p. S76-S77
2 p.
 artikel
195 P36 Silencing of IGF-IR and IGF-I induce antitumoral immune response in breast cancer model Durfort, T.
 2010
 20 S1 p. S52-S53
2 p.
 artikel
196 P46 Studies on the bivalent interaction of IGF-II with the insulin and type 1 IGF receptors Alvino, C.L.
 2010
 20 S1 p. S56-
1 p.
 artikel
197 P33 Targeting of the IGF-IR as a potential therapeutic strategy in endometrial cancer Attias-Geva, Z.
 2010
 20 S1 p. S51-
1 p.
 artikel
198 P94 The effects of freeze-thaw treatment and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal peptide concentrations Guha, N.
 2010
 20 S1 p. S74-
1 p.
 artikel
199 P84 The effects of recombinant human IGF-I/IGF-binding protein-3 on glucose homeostasis in recreational athletes Guha, N.
 2010
 20 S1 p. S69-S70
2 p.
 artikel
200 P62 The effects of type I IGF receptor inhibition with small-molecule diarylureas in a mouse model of type I diabetic kidney disease Troib, A.
 2010
 20 S1 p. S61-
1 p.
 artikel
201 P93 The growth hormone receptor exon 3 deleted/full-length polymorphism tagSNP rs6873545 is associated with obesity-related parameters in a randomly selected population Glad, C.A.M.
 2010
 20 S1 p. S73-S74
2 p.
 artikel
202 P97 The identification of heterozygous CUL7 sequence variants in a cohort of children born with a low birth weight Saunders, E.
 2010
 20 S1 p. S75-
1 p.
 artikel
203 P105 The IGF-I and IGFBP-3 response after two years of growth hormone treatment using recommended doses differs in children with growth hormone deficiency, small-for-gestational age status, Ullrich-Turner and Prader-Willi syndrome: implications for treatment? Hauffa, B.P.
 2010
 20 S1 p. S79-
1 p.
 artikel
204 P38 The IGF-II receptor regulates the metastatic properties of prostate cancer cells through the cross-talk with IGF-I and integrins receptors Losada-Barragán, M.
 2010
 20 S1 p. S53-
1 p.
 artikel
205 P85 The production and regulation of insulin-like growth factor (IGF) I and II and IGF-binding proteins in human adipose tissue cultures Rasmussen, M.F.
 2010
 20 S1 p. S70-
1 p.
 artikel
206 P32 The role of lipids in mammary cancer growth Alikhani, N.
 2010
 20 S1 p. S51-
1 p.
 artikel
207 P8 Thyroid function and ultrasound evaluation in patients with acromegaly Fukuda, I.
 2010
 20 S1 p. S41-S42
2 p.
 artikel
208 P4 Twelve months efficacy and safety of a novel once-a-week sustained release rhGH (LB03002): a phase III study in adults with GHD Biller, B.M.K.
 2010
 20 S1 p. S40-S41
2 p.
 artikel
209 P109 Up-regulation of IGFBP-2 following a controlled cortical impact injury Qin, M.
 2010
 20 S1 p. S80-S81
2 p.
 artikel
210 P54 Variations of 40 signaling proteins in two Ewing's Sarcoma xenografts following treatment with RG1507, a human IgG1 monoclonal antibody targeting IGF-1R Hofmann, M.H.
 2010
 20 S1 p. S58-S59
2 p.
 artikel
211 Scientific Program 2010
 20 S1 p. vii-xvi
nvt p.
 artikel
                             211 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland